Predicting Treatment Response in Primary Aldosteronism Using 11C-Metomidate Positron Emission Tomography
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004369
Abstract: Background Appropriate treatment of primary aldosteronism (PA) depends on accurate lateralization. 11C-metomidate (MTO) is a tracer used in PET that provides functional information about the adrenal cortex. We aimed to perform MTO PET for patients… read more here.
Keywords: hsuvmax lsuvmax; 11c metomidate; primary aldosteronism; lateralization ... See more keywords